ArticleJHEP reports : innovation in hepatology2023

Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study.

Benjamin Maasoumy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.